Simultaneous Determination of Simvastatin and Ezetimibe in Tablets by HPLC

被引:12
作者
Kumar, D. Anantha [1 ]
Sujan, D. P. [1 ]
Vijayasree, V. [1 ]
Rao, J. V. L. N. Seshagiri [1 ]
机构
[1] Andhra Univ, AU Coll Pharmaceut Sci, Visakhapatnam 530003, Andhra Pradesh, India
关键词
Simvastatin; Ezetimibe; Determination; HPLC; PERFORMANCE LIQUID-CHROMATOGRAPHY; PHARMACEUTICAL DOSAGE FORMS; HUMAN PLASMA; PRIMARY HYPERCHOLESTEROLEMIA; MASS-SPECTROMETRY; LOVASTATIN; EFFICACY; SAFETY;
D O I
10.1155/2009/626343
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A reverse phase high performance liquid chromatographic method was developed for the simultaneous determination of simvastatin and ezetimibe in tablet dosage forms. The separation was effected on a C18 Supelcosil column ( 250 mm x 4.6 mm; 5 mu) using a mobile phase consisting of 0.01 M ammonium acetate buffer and acetonitrile ( 35: 65 v/v) at a flow rate of 1 mL/min. The detection was made at 240 nm. The retention times for ezetimibe and simvastatin were 5.9 and 8.5 min respectively. Calibration curves were linear over the ranges of 0.5-40 mu g/mL for simvastatin and 2.5-50 mu g/mL for ezetimibe. The proposed method was validated as per the ICH and USP guidelines. The method is accurate and precise and found to be suitable for the quantitative analysis of both the drugs individually and in combination in tablet dosage forms.
引用
收藏
页码:541 / 544
页数:4
相关论文
共 12 条
[1]   SIMULTANEOUS DETERMINATION OF SIMVASTATIN AND ITS HYDROXY ACID FORM IN HUMAN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH UV DETECTION [J].
CARLUCCI, G ;
MAZZEO, P ;
BIORDI, L ;
BOLOGNA, M .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1992, 10 (09) :693-697
[2]   Efficacy and safety of Ezetimibe coadministered with Lovastatin in primary hypercholesterolemia [J].
Kerzner, B ;
Corbelli, J ;
Sharp, S ;
Lipka, LJ ;
Melani, L ;
LeBeaut, A ;
Suresh, R ;
Mukhopadhyay, P ;
Veltri, EP .
AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (04) :418-424
[3]   Efficacy and safety of ezetimibe coadministered with pravastatin in patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial [J].
Melani, L ;
Mills, R ;
Hassman, D ;
Lipetz, R ;
Lipka, L ;
LeBeaut, A ;
Suresh, R ;
Mukhopadhyay, P ;
Veltri, E .
EUROPEAN HEART JOURNAL, 2003, 24 (08) :717-728
[4]   Determination of simvastatin and its active metabolite in human plasma by column-switching high-performance liquid chromatography with fluorescence detection after derivatization with 1-bromoacetylpyrene [J].
Ochiai, H ;
Uchiyama, N ;
Imagaki, K ;
Hata, S ;
Kamei, T .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 1997, 694 (01) :211-217
[5]   A LC-MS/MS method to quantify the novel cholesterol lowering drug ezetimibe in human serum, urine and feces in healthy subjects genotyped for SLCO1B1 [J].
Oswald, S ;
Scheuch, E ;
Cascorbi, I ;
Siegmund, W .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2006, 830 (01) :143-150
[6]   Development and validation of a reversed-phase HPLC method for the determination of ezetimibe in pharmaceutical dosage forms [J].
Sistla, R ;
Tata, VSSK ;
Kashyap, YV ;
Chandrasekar, D ;
Diwan, PV .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2005, 39 (3-4) :517-522
[7]   Determination of lovastatin and simvastatin in pharmaceutical dosage forms by MEKC [J].
Srinivasu, MK ;
Raju, AN ;
Reddy, GO .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2002, 29 (04) :715-721
[8]  
TOKANO T, 1990, BIOMED ENVIRON MASS, V19, P577
[9]  
VANHEEK M, 1997, PHARM EXP THER, V283, P157
[10]   Identification of unknown impurities in simvastatin substance and tablets by liquid chromatography/tandem mass spectrometry [J].
Vuletic, M ;
Cindric, M ;
Koruznjak, JD .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2005, 37 (04) :715-721